HOWL Werewolf Therapeutics
- 5.720
- -0.260-4.35%
Werewolf Therapeutics News
Werewolf Therapeutics | 8-K: Werewolf Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Werewolf Therapeutics | DEFA14A: Others
Werewolf Therapeutics | DEF 14A: Definitive information statements
Werewolf Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Werewolf Therapeutics | 8-K: Werewolf Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Werewolf Therapeutics | 8-K: Current report
Werewolf Therapeutics | 8-K: Current report
Werewolf Therapeutics | 8-K: Current report
Werewolf Therapeutics | 8-K: Werewolf Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
Werewolf Therapeutics | 8-K: Current report
Werewolf Therapeutics | 8-K: Current report
Werewolf Therapeutics | 8-K: Werewolf Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
Werewolf Therapeutics | 8-K: Current report
Werewolf Therapeutics | 8-K: Werewolf Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
Werewolf Therapeutics | DEFA14A: Others
Werewolf Therapeutics | DEF 14A: Definitive proxy statements
Werewolf Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Werewolf Therapeutics | 8-K: Werewolf Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Werewolf Therapeutics | 8-K: Current report
Werewolf Therapeutics | 8-K: Current report
Analysis
Price Target
No Data
